Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Gastrointestinal Diseases

Interventions

DRUG

5-Fluorouracil

2.2 Gm/m\^2 IV over 48 hours on Day 1.

DRUG

Docetaxel

20 mg/m\^2 IV over 60 minutes

DRUG

Oxaliplatin

85 mg/m\^2 IV over 120 minutes on Day 1.

Trial Locations (1)

University of Texas MD Anderson Cancer Center, Houston